Immunotherapy

These therapies offer options to people with advanced or treatment-resistant cancer. Montefiore Einstein Cancer Center is actively involved in the discovery and testing of new immunotherapy strategies to more precisely target and treat both common and rare cancers. Our research breakthroughs continue to lead game-changing cancer immunotherapy treatment practices and give patients the opportunity to join upcoming clinical trials. 

At Montefiore Einstein Cancer Center, our dedicated, world-renowned team offers leading-edge immunotherapy treatments for people with advanced cancers. Many of these treatments are already approved by the Food and Drug Administration (FDA). Others are available only through clinical trials at certain places, including our Cancer Center.  

To provide truly personalized care, a dedicated team of highly skilled cancer specialists is built around you, with experts who specialize in your type of cancer and understand your lifestyle. Our multidisciplinary approach helps provide a quicker and more accurate diagnosis, and may utilize immunotherapies alone or in combination with standard treatment approaches, such as surgery, to treat your cancer.  

Immunotherapy treatment uses a process very similar to bone marrow transplantation. With extensive experience and expertise in bone marrow transplantation, Montefiore Einstein Cancer Center has the advanced knowledge and resources needed to provide this complex therapy. 

Our Cancer Center is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) for the full spectrum of adult and pediatric stem cell transplant procedures. We are one of only a few cancer centers in the country with this accreditation, recognizing that our team is of the highest caliber and offers state-of-the-art immunotherapy and bone marrow transplant care. 

Immunotherapy is a type of precision medicine that personalizes a person’s treatment plan based on their genetics, environment, lifestyle and other factors.   

With precision medicine, we use specific tests to pinpoint which treatment regimen is most likely to benefit you. Montefiore Einstein Cancer Center is at the forefront of this approach, and one of the first centers in the New York region to provide genetic testing options that identify who is more likely to benefit from immunotherapy versus chemotherapy.